null

null

null

null

null

null

null

null

null

null

null

null

null

null

null

null

null

null

Micro-cap cannabis penny stock; minimal formal debt but high dilution risk; 20% rate rise negligibly impacts interest expense but crushes equity valuation multiples further.

Near-zero fixed-rate debt exposure; rate sensitivity is indirect via cost of capital for future raises; 20% rate increase materially raises dilution cost of equity financing.

Medium intensity; US-China trade tariffs on metals and components disrupt supply chains.

Top chokepoints: (1) U.S. state-level cannabis licensing bottlenecks; (2) domestic agricultural input suppliers concentrated in California and Colorado.

Operations primarily U.S.-domestic; negligible international revenue; sovereign currency devaluation exposure is effectively zero across all markets.

U.S.-only operational footprint; revenue concentrated in domestic cannabis markets; no material foreign-currency revenue exposure identified.

Medium intensity; commodities: Steel, Aluminum, Copper, Crude Oil (fuel), Rare Earth Elements, Plastics/Resins; geopolitical: US-China trade tariffs on metals and components disrupt supply chains.

Cannabis cultivation inputs and licensed processing partners likely represent substitutable vendors; no single API or tech vendor appears to exceed 30% operational input cost.

Physical cannabis product sales and cultivation; not cloud-dependent; AWS/GCP/Azure termination would cause minor website disruption, not operational collapse.

Asset-light ancillary cannabis services and licensing; digital infrastructure minimal; cloud termination risk rated low given limited SaaS or platform component.

Minimal API coupling risk; no significant proprietary platform integrations identified; switching costs for customers and vendors are low.

Primary revenue from cannabis product sales; does not meet Howey Test criteria; no expectation-of-profit-from-others structure; securities risk from equity issuance only.

Medium

Minimal GDPR exposure given U.S.-only operations; limited CCPA risk given small consumer data footprint; compliance infrastructure likely underdeveloped for a micro-cap.

Negligible antitrust risk; company is a micro-cap with minimal market share in fragmented cannabis industry; no dominant market position to attract regulatory scrutiny.

Medium burden; regimes: FAA, DOT, OSHA, EPA, ITAR, FTC; Export controls and defense procurement rules create contract concentration risk.

Predominantly transactional (product sales); recurring revenue estimated below 10% of total; no meaningful subscription or multi-year contract revenue base identified.

Direct cannabis product sales (flower, extracts, edibles); secondary licensing/IP monetization attempted but immaterial to total revenue.

Commodity-style pricing in highly competitive cannabis market; limited pricing power; margin compression risk high under input cost inflation or state tax increases.

Low; cannabis is commoditizing rapidly; WEED Inc. lacks brand premium or differentiation sufficient to sustain above-market pricing.

Estimated gross margin 20–40%; cannabis cultivation and processing margins are compressed by state taxes, compliance costs, and commodity pricing pressure.

High churn vulnerability; no loyalty infrastructure or subscription model; customers transact freely across dispensaries with zero switching cost.

Revenue growth is largely headcount-linear; cultivation and processing are labor-intensive; doubling revenue likely requires near-doubling of operational staff.

High marginal cost of growth; physical cannabis operations require proportional labor, facility, and compliance cost increases with each revenue increment.

null

Unit economics at 10x scale remain challenged; CAC likely rises with competition; LTV is low given no recurring model; 10x scale requires significant capital and licenses.

No network effects present; cannabis product sales are transactional and non-networked; user growth does not increase product value for other users.

-245.1% Return on Assets (Negative equity)

Moderate recession resistance; cannabis has shown demand inelasticity in downturns, but micro-cap operational fragility offsets sector resilience.

Retail cannabis consumers (recreational and medical); highly fragmented with no single customer representing material revenue concentration.

Wholesale dispensary and distribution partners; concentration risk possible if one or two state-licensed distributors represent majority of B2B volume.

["11-0000 Management Occupations", "13-0000 Business and Financial Operations Occupations", "15-0000 Computer and Mathematical Occupations", "17-0000 Architecture and Engineering Occupations", "23-0000 Legal Occupations", "33-0000 Protective Service Occupations", "37-0000 Building and Grounds Cleaning and Maintenance Occupations", "41-0000 Sales and Related Occupations", "43-0000 Office and Administrative Support Occupations", "47-0000 Construction and Extraction Occupations", "49-0000 Installation, Maintenance, and Repair Occupations", "51-0000 Production Occupations", "53-0000 Transportation and Material Moving Occupations"]

0.3 (HIL — ~30% of characteristic roles agent-automatable)

Capital appears consumed by sustaining current cultivation and compliance operations rather than future-state infrastructure; no evidence of strategic capex reallocation.

0001393772

BUDZ